论文信息 - Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024 - 字舞流文

Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024

R. Link-Gelles | F. Dawood | R. Selvarangan | J. Boom | D. Zerr | M. Staat | E. Schlaudecker | C. Pulido | Bonnie Strelitz | D. Banerjee | A. Sasidharan | V. Avadhanula | Chelsea C. Rohlfs | Leila C. Sahni | Ayzsa Tannis | Wende Fregoe | Erin McKeever | Klancie Dauer | Christina Albertin | Ryan Wiegand | P. A. Piedra | Jennifer E. Schuster | Janet A Englund | Laura S Stewart | M. McMorrow | Natasha B. Halasa | Heidi L Moline | Ariana P Toepfer | John V. Williams | Geoffrey A. Weinberg | Marian G Michaels | Eileen J. Klein | Peter G. Szilagyi | Leah Goldstein | Samar Musa | Kristina A. Betters | Casey Kalman | Benjamin R. Clopper | Amanda B. Payne | Ximena Aguilera Correa | Hanna Grioni | Flor M Muñoz | Saranya Peri | Monika Johnson